NFKB1 and colorectal carcinoma: (45) demonstrated that elevated NOS2 expression has been shown to reduce tumorigenicity in vivo and inhibit CRC cell proliferation and survival by inducing apoptosis through suppression of the NF-κB signaling pathway.